# CSP Inc: overview CSPI · Nasdaq · CIK 356037 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/cspi.md) · [Financials](/companies/cspi/financials.md) · [Filings](/companies/cspi/filings.md) · [Insiders](/companies/cspi/insiders.md) Latest reported revenue: [$14.4m](/filings/0000356037-26-000045.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0000356037-26-000045). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [13.0 d](/filings/0000356037-25-000065.md) | [15.7](/filings/0000356037-26-000008.md) | [13.1](/filings/0000356037-26-000027.md) | [15.4](/filings/0000356037-26-000045.md) | [14.5 d](/filings/0000356037-25-000065.md) | [12.0](/filings/0000356037-26-000008.md) | [16.0](/filings/0000356037-26-000027.md) | [14.4](/filings/0000356037-26-000045.md) | | Gross margin | % | [28.4% d](/filings/0000356037-25-000065.md) | [29.1%](/filings/0000356037-26-000008.md) | [32.0%](/filings/0000356037-26-000027.md) | [28.8%](/filings/0000356037-26-000045.md) | [36.6% d](/filings/0000356037-25-000065.md) | [39.3%](/filings/0000356037-26-000008.md) | [27.9%](/filings/0000356037-26-000027.md) | [30.1%](/filings/0000356037-26-000045.md) | | Operating margin | % | [(15.7%) d](/filings/0000356037-25-000065.md) | [(2.3%)](/filings/0000356037-26-000008.md) | [(7.6%)](/filings/0000356037-26-000027.md) | [(7.9%)](/filings/0000356037-26-000045.md) | [(3.7%) d](/filings/0000356037-25-000065.md) | [(0.9%)](/filings/0000356037-26-000008.md) | [(5.3%)](/filings/0000356037-26-000027.md) | [(10.7%)](/filings/0000356037-26-000045.md) | | Net margin | % | [(12.7%) d](/filings/0000356037-25-000065.md) | [3.0%](/filings/0000356037-26-000008.md) | [(0.8%)](/filings/0000356037-26-000027.md) | [(1.7%)](/filings/0000356037-26-000045.md) | [(1.3%) d](/filings/0000356037-25-000065.md) | [0.8%](/filings/0000356037-26-000008.md) | [1.6%](/filings/0000356037-26-000027.md) | [(5.9%)](/filings/0000356037-26-000045.md) | | Diluted EPS | $ per share | not reported | [0.05](/filings/0000356037-26-000008.md) | [(0.01)](/filings/0000356037-26-000027.md) | [(0.03)](/filings/0000356037-26-000045.md) | not reported | [0.01](/filings/0000356037-26-000008.md) | [0.03](/filings/0000356037-26-000027.md) | [(0.09)](/filings/0000356037-26-000045.md) | | Free cash flow | $m | [(1.5) d](/filings/0000356037-25-000065.md) | [1.7](/filings/0000356037-26-000008.md) | [1.9 d](/filings/0000356037-26-000027.md) | [(3.3) d](/filings/0000356037-26-000045.md) | [1.7 d](/filings/0000356037-25-000065.md) | [(3.0)](/filings/0000356037-26-000008.md) | [(0.5) d](/filings/0000356037-26-000027.md) | [0.4 d](/filings/0000356037-26-000045.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [49.2](/filings/0000356037-22-000036.md) | [54.4](/filings/0000356037-23-000045.md) | [64.6](/filings/0000356037-24-000070.md) | [55.2](/filings/0000356037-25-000065.md) | [58.7](/filings/0000356037-25-000065.md) | | Gross margin | % | [32.8%](/filings/0000356037-22-000036.md) | [34.6%](/filings/0000356037-23-000045.md) | [33.9%](/filings/0000356037-24-000070.md) | [34.1%](/filings/0000356037-25-000065.md) | [31.5%](/filings/0000356037-25-000065.md) | | Operating margin | % | [(2.8%)](/filings/0000356037-22-000036.md) | [(0.1%)](/filings/0000356037-23-000045.md) | [2.9%](/filings/0000356037-24-000070.md) | [(3.4%)](/filings/0000356037-25-000065.md) | [(5.3%)](/filings/0000356037-25-000065.md) | | Net margin | % | [1.4%](/filings/0000356037-22-000036.md) | [3.5%](/filings/0000356037-23-000045.md) | [8.0%](/filings/0000356037-24-000070.md) | [(0.6%)](/filings/0000356037-25-000065.md) | [(0.2%)](/filings/0000356037-25-000065.md) | | Diluted EPS | $ per share | [0.16](/filings/0000356037-22-000036.md) | [0.42](/filings/0000356037-23-000045.md) | [0.55](/filings/0000356037-24-000070.md) | [(0.04)](/filings/0000356037-25-000065.md) | [(0.01)](/filings/0000356037-25-000065.md) | | Free cash flow | $m | [1.8](/filings/0000356037-22-000036.md) | [2.4](/filings/0000356037-23-000045.md) | [3.7](/filings/0000356037-24-000070.md) | [4.0](/filings/0000356037-25-000065.md) | [1.9](/filings/0000356037-25-000065.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cspi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Visionary Wealth Advisors](/funds/1802984.md) | 2026-06-30 | $6.4m | 801,088 | | Added +16,277 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.8m | 354,154 | | Reduced −276 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $2.8m | 351,674 | | Reduced −8,379 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.1m | 267,714 | | Reduced −9,712 | | [Savvy Advisors, Inc.](/funds/2003633.md) | 2026-06-30 | $754.2k | 94,985 | | New +94,985 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $647.2k | 81,477 | | Reduced −94,555 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $552.7k | 69,612 | | New +69,612 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $511.9k | 64,470 | | Reduced −304,707 | | [Integrated Wealth Concepts LLC](/funds/1737109.md) | 2026-06-30 | $374.4k | 47,151 | | Added +23,590 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $369.2k | 46,500 | | Added +91 | ## Recent filings [All 655 filings](/companies/cspi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-14 | 16:01 ET | [8-K](/filings/0000356037-26-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000356037-26-000050 | | 2026-08-14 | 14:31 ET | [10-Q](/filings/0000356037-26-000045.md) | Quarterly report, period 2026-06-30 | 0000356037-26-000045 | | 2026-06-09 | 11:42 ET | [8-K](/filings/0000356037-26-000033.md) | 5.02 Departure or appointment of officers or directors | 0000356037-26-000033 | | 2026-05-07 | 12:26 ET | [10-Q](/filings/0000356037-26-000027.md) | Quarterly report, period 2026-03-31 | 0000356037-26-000027 | | 2026-05-07 | 08:41 ET | [8-K](/filings/0000356037-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000356037-26-000024 | | 2026-03-16 | 10:25 ET | [8-K](/filings/0000356037-26-000016.md) | 5.02 Departure or appointment of officers or directors | 0000356037-26-000016 | | 2026-02-13 | 14:06 ET | [8-K](/filings/0000356037-26-000011.md) | 5.07 Shareholder vote results | 0000356037-26-000011 | | 2026-02-12 | 16:13 ET | [10-Q](/filings/0000356037-26-000008.md) | Quarterly report, period 2025-12-31 | 0000356037-26-000008 | | 2026-02-12 | 09:01 ET | [8-K](/filings/0000356037-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000356037-26-000005 | | 2025-12-30 | 11:22 ET | [DEF 14A](/filings/0000356037-25-000070.md) | Proxy statement, period 2026-02-10 | 0000356037-25-000070 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0000356037-25-000065.md), filed Dec 16, 2025. ## Forecast league Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/24492bd8-3ef3-4cf6-8d5f-4ac35fceac83) ## About the filer - CIK: 356037 - Tickers: CSPI - Exchange: Nasdaq - SIC code: 7373 Services-Computer Integrated Systems Design - State of incorporation: MA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.